Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models: APP Mutations
APP Swedish Tg2576

General Information

Transgene:     Human APP695 cDNA

Mutation:       APP695 with double mutations at KM670/671NL

Promoter:       hamster prion protein gene promoter 

Mouse Strain:   C57B6j X SJL F1 hybrid mice backcrossed N1 or N2 generations to C57B6j

Phenotype

Neuropathological analysis:

Brain transgenic APP was 5.6 times more than endogenous APP.  A fivefold increase in Ab(1-40) and a 14 fold increase in Ab(1-42/43) over levels measure in young, unimpaired transgenic mice.

Numerous Ab plaques stained with Congo red dye in cortical and limbic structures of mice with elevated amount of Ab.

Plaque load in these mice ranged from 3.6 to 8.5% in selected cellular inflammatory response. Amyloid angiopathy appeared in some vessels. Markers to oxidative lipid and glycoxidative damages as well as to the antioxidant defense enzymes heme-oxygenase and superoxide dismutase were increased in transgenic animals.

Neither neuronal loss in the CA1 region nor loss of synaptic density in the dentate gyrus of hippocampi in aged mice was detected.

Behavioral:  

Normal spatial reference memory in N2 mice at 3 months. In a forced alternation paradigm and spatial reference memory in a water maze were impaired in N2 mice at 14-16 months.

9-10 months N1 mice: spatial reference impairment.

Availability

Taconic Farm Emerging Model 
TgN(APPSWE)2576  Model #001349-T/W 

Patent:

Patent No. Title Assignee/Inventors Filing Date Issue Date
5,877,399 Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease Johns Hopkins University; Regents of the University of Minnesota /Hsiao; Karen; Borchelt; David R.; Sisodia; Sangram S. 6/17/96 3/2/99

Reference

Primary:

Hsiao, K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. Correlative memory deficits, Ab elevation, and amyloid plaques in transgenic mice. Science 274:99-102, Oct 4, 1996. Abstract.

Associated:

Kawarabayashi T, Younkin L, Saido T, Shoji M, Ashe K, Younkin S. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 2001 Jan 15;21(2):372-81. Abstract.

Frautschy SA, Yang F, Irrizarry M, Hyman B, Saido TC, Hsiao K, Cole GM. Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol 1998 Jan;152(1):307-17. Abstract.

Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 1997 Sep;56(9):965-73. Abstract.

Lehman E J, Kulnane LS, Lamb BT. Alterations in b-amyloid production and deposition in brain regions of two transgenic models. Neurobiol Aging 24 (5):645-653, 2003. Abstract

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad